by novabioticsadm1n | Mar 19, 2019 | 2019, Press Releases
Date posted: March 19, 2020 Three Posters on New Lynovex Preclinical and Clinical Data to be presented at NACFC, 31st October to 2nd November 2019, Nashville Tennessee. Dr Douglas Fraser-Pitt will present three posters on Thursday 31st October 2019...
by novabioticsadm1n | Mar 19, 2019 | 2019, Press Releases
Date posted: March 19, 2020 Congratulations to Amanda Nicolson, winner of the Novabiotics Prize: Best IBMS Registration Training Portfolio at the 11th July 2019 prize-giving ceremony held at Robert Gordon University, Garthdee Campus in Aberdeen. Categories Press...
by novabioticsadm1n | Mar 19, 2019 | 2019, Press Releases
Date posted: March 19, 2020 NovaBiotics will present new efficacy data for their Lynovex® Cystic Fibrosis (CF) drug candidates at the European CF Society Conference (ECFS) in Liverpool, UK, June 5th-8th. ECFS is a major international event and provides a forum for all...
by novabioticsadm1n | Mar 19, 2019 | 2019, Press Releases
Date posted: March 19, 2020 NovaBiotics are pleased to announce that we will be participating in the 42nd European Cystic Fibrosis Conference (ECFS); 5-8 June 2019, Liverpool. Our team will be presenting exciting new data on the antimicrobial mechanism of action,...
by novabioticsadm1n | Mar 19, 2019 | 2019, Press Releases
Date posted: March 19, 2020 The manuscript is entitled “Improved Methods for Assessing Therapeutic Potential of Antifungal Agents Against Dermatophytes and their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate”. The...
Recent Comments